Placebo capsules

Phase 2

UUniversity of Minnesota

Placebo capsules is one of 39 therapeutic programs targeting Alopecia Areata. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Alopecia AreataRecruiting

Liver ResectionRecruiting

Alopecia AreataPhase 2

Recruiting

Liver ResectionPreclinical

Recruiting

Competition

Competitive Landscape

113 competitors in Alopecia Areata

#DrugCompanyPhaseTrials

Opzelura

Pfizer

Phase 3

5 2

Olumiant

Eli Lilly

Phase 3

5 3

Rinvoq

AbbVie

Phase 3

2 4

PF-06651600

Pfizer

Phase 3

4 5

Orencia

Bristol-Myers Squibb

Phase 2

2 6

Jaktinib

SSuzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3

4 7

Jakafi

Incyte

Phase 2

1 8

Cosentyx

Novartis

Phase 2

1 9

Velsipity

Pfizer

Phase 2

1 10

SHR0302

RReistone Biopharma Company Limited

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Liver Resection

NCT06638502

Q1 2028

Phase 2Recruiting

Alopecia Areata

NCT06747611

Clinical

Trials by Indication[1]

Liver Resection1 trial

Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of HRX215 in Participants After Major Hepatectomy, Preceded by Two Open Pilot Parts in Participants After Minor and After Major Hepatectomy Due to Colon Carcinoma Metastases

Recruiting·HHepaRegeniX GmbH·Preclinical·NCT06638502·80 enrolled

Alopecia Areata1 trial

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Recruiting·UUniversity of Minnesota·Phase 2·NCT06747611·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Placebo capsules. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Placebo capsules. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — University of Minnesota company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: UUniversity of Minnesota

Placebo capsules

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q1 2028

Trials by Indication[1]

Liver Resection1 trial

Alopecia Areata1 trial

References

Drug Info

Quick Facts

Related News